College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Cancer Biomark. 2018;22(3):511-521. doi: 10.3233/CBM-171160.
Liver carcinoma is a major cause of cancer-related death worldwide. Up to date, the mechanisms of liver cancerigenesis and development have not been fully understood. Multi-genes and pathways were involved in the tumorigenesis of liver cancer.
The aim of the present study was to screen key genes and pathways in liver cancerigenesis and development by using bioinformatics methods.
A dataset GSE64041 were retrieved from GEO database and the differentially expressed genes (DEGs) were screened out. Then the DEG functions were annotated by gene ontology (GO) and pathway enrichment analysis, respectively. The hub genes were further selected by protein-protein interaction (PPI) analysis. Afterwards, the mRNA and protein expressions as well as the prognostic values of the hub genes were assessed.
As a result, 208 up-regulated and 82 down-regulated genes were screened out. These DEGs were mainly enriched in cell cycle and metabolism-related pathways. Through PPI analysis, TOP2A, PRDM10, CDK1, AURKA, BUB1, PLK1, CDKN3, NCAPG, BUB1B and CCNA2 were selected as hub genes, which were all over-expressed in liver cancers relative to those in normal tissues, respectively. Among them, PLK1 and CCNA2 were suggested to be prognostic factors for liver carcinoma.
In conclusion, the present study identified several hub genes, and cell cycle and metabolism-related pathways that may play critical roles in the tumorigenesis of liver cancer. Future validation laboratory experiments are required to confirm the results.
肝癌是全球癌症相关死亡的主要原因。迄今为止,肝癌的发生和发展机制尚未完全阐明。多种基因和途径参与肝癌的发生。
本研究旨在通过生物信息学方法筛选肝癌发生发展的关键基因和途径。
从 GEO 数据库中检索数据集 GSE64041,筛选差异表达基因(DEGs)。然后分别通过基因本体(GO)和通路富集分析对 DEG 功能进行注释。通过蛋白质-蛋白质相互作用(PPI)分析进一步选择核心基因。随后,评估核心基因的 mRNA 和蛋白表达水平及其预后价值。
共筛选出 208 个上调和 82 个下调基因。这些 DEGs 主要富集在细胞周期和代谢相关通路中。通过 PPI 分析,选择 TOP2A、PRDM10、CDK1、AURKA、BUB1、PLK1、CDKN3、NCAPG、BUB1B 和 CCNA2 作为核心基因,它们在肝癌组织中的表达均高于正常组织。其中,PLK1 和 CCNA2 被认为是肝癌的预后因素。
本研究鉴定了一些核心基因和与细胞周期和代谢相关的途径,它们可能在肝癌的发生中起关键作用。需要进一步的验证实验室实验来证实这些结果。